MedPath

Vagal Nerve Stimulation as an Alternative Therapy for Premature Ventricular Contractions

Phase 3
Withdrawn
Conditions
Premature Ventricular Contraction
Registration Number
NCT06110364
Lead Sponsor
Hunter Holmes Mcguire Veteran Affairs Medical Center
Brief Summary

Prospective randomized control pilot study

Detailed Description

The primary aims of this investigator initiated study is :

Aim 1: to assess the ability of non-invasive vagal nerve stimulation to suppress Premature Ventricular Contractions and Aim 2: to compare the efficacy of Lower-level Tragus stimulation and Heart rate variability- Biofeedback in suppression of Premature Ventricular Contractions.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Normal Left Ventricular systolic function
  • Frequent PVCs
Exclusion Criteria
  • Current use of any (I and/or III) antiarrhythmic medication
  • Contraindication to use beta blockers and non-dihydropyridine calcium channel blockers
  • Complete Atrioventricular block and pacemaker dependent
  • Ongoing uncontrolled hypertension with systolic Blood Pressure> 180
  • Family history of dilated Cardiomyopathy in a first degree relative
  • Alcohol use disorder or illicit drug use
  • Actively being treated Atrial fibrillation/ Flutter with Rapid Ventricular Response
  • Moderate to severe valve disorders
  • Patient with shortwave/microwave therapy equipment

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Assess the ability of non-invasive vagal nerve stimulation to suppress Premature Ventricular Contractions.perspective 12-week study (each arm lasting two weeks with a one week washout between each arm)

Compare the effects of Premature Ventricular Contractions suppression between standard medical therapy and non-invasive vagal nerve stimulation.

Secondary Outcome Measures
NameTimeMethod
Compare the efficacy of non-invasive vagal nerve stimulation via lower-level vagal stimulation and heart rate variability in suppression of Premature Ventricular Contractions.perspective 12-week study (each arm lasting two weeks with a one-week washout between each arm)

It is speculated that Heart Rate Variability-Biofeedback is as effective as Lower Level Tragus Stimulation to achieve successful Premature Ventricular Contraction suppression.

Trial Locations

Locations (1)

Richmond VA Medical Center

🇺🇸

Richmond, Virginia, United States

Richmond VA Medical Center
🇺🇸Richmond, Virginia, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.